Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary extracted from

  • Paritala, H.; Suzuki, Y.; Carroll, K.
    Design, synthesis and evaluation of Fe-s targeted adenosine 5'-phosphosulfate reductase inhibitors (2015), Nucleosides Nucleotides Nucleic Acids, 34, 199-220 .
    View publication on PubMedView publication on EuropePMC

Crystallization (Commentary)

EC Number Crystallization (Comment) Organism
1.8.4.10 virtual ligand docking simulations with inhibitors. For 2-[(2R,3S,4R,5R)-3,4-dihydroxy-5-[6-[(2-sulfanylethyl)amino]-9H-purin-9-yl]oxolan-2-yl]ethyl phosphate, the AMP scaffold binds within the substrate-binding pocket and establishes interactions with key active site residues Mycobacterium tuberculosis

Inhibitors

EC Number Inhibitors Comment Organism Structure
1.8.4.10 2-[(2R,3S,4R,5R)-3,4-dihydroxy-5-[6-[(2-sulfanylethyl)amino]-9H-purin-9-yl]oxolan-2-yl]ethyl phosphate best inhibitor analyzed. The S atom is capable of establishing favorable interactions with the Fe-S cluster Mycobacterium tuberculosis
1.8.4.10 additional information analysis of inhibitors and molecular docking shows a clearly defined spacing requirement between the Fe-S targeting group and adenosine scaffold. Smaller Fe-S targeting groups are better tolerated. The S atom of the most potent inhibitor may establish a favorable interaction with an S atom in the cluster Mycobacterium tuberculosis

Organism

EC Number Organism UniProt Comment Textmining
1.8.4.10 Mycobacterium tuberculosis
-
-
-

Cofactor

EC Number Cofactor Comment Organism Structure
1.8.4.10 [4Fe-4S]-center
-
 Mycobacterium tuberculosis